Results 21 to 30 of about 409,848 (384)
Journal of the American Medical Association (JAMA), 2021 Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca), which uses a chimpanzee adenoviral vector.
I. See +23 more
semanticscholar +1 more source
Thrombocytopenia in pregnancy: is this immune thrombocytopenia or…? [PDF]
Hematology, 2012 Abstract Thrombocytopenia is a common finding in pregnancy. Establishing the diagnosis of immune thrombocytopenia (ITP) in a pregnant patient is similar to doing so in a nonpregnant patient, except that the evaluation must specifically rule out other disorders of pregnancy associated with low platelet counts that present different risks ...
Terry Gernsheimer, Terry Gernsheimer
openaire +3 more sources
Thrombocytopenia is more Frequent in Gram negative Neonatal Septicemia [PDF]
Pediatric Sciences Journal, 2022 Background: Sepsis is one of the major causes of neonatal thrombocytopenia. Aim of the work: To identify the frequency, severity, and clinical outcome of thrombocytopenia associated with culture-proven neonatal septicemia in the Neonatal Intensive ...
Eman Abobakr Abd Alazem +3 more
doaj +1 more source
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
American journal of hematology/oncology, 2021 Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention.
Eun-Ju Lee +10 more
semanticscholar +1 more source
British medical journal, 2021 Objective To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations.
A. Pottegård +15 more
semanticscholar +1 more source
Global Pediatric Health, 2021 Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis and providing accurate management in rare causes of ...
Mobin Paul MBBS, MD, DM +4 more
doaj +1 more source
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. [PDF]
, 2016 Preclinical models suggest that histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors have synergistic anticancer activity. We designed a phase I study to determine the safety, maximum tolerated dose (MTD), recommended phase II ...
Falchook, Gerald S. +17 more
core +5 more sources
Platelets, 2022 Thrombocytopenia is common in critical illness. But there are no studies that focus on thrombocytopenia and platelet recovery in Sepsis-3 patients. We employed a large database to identify sepsis based on Sepsis-3 criteria. Patients were grouped by nadir
Hui Zhou +3 more
doaj +1 more source
Annals of Internal Medicine, 2022 Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thrombosis with thrombocytopenia syndrome occurring after receipt of COVID-19 vaccines in the United States were determined.
I. See +23 more
semanticscholar +1 more source
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Blood, 2021 SARS-CoV-2 vaccine ChAdOx1 nCov-19 (AstraZeneca) causes a thromboembolic complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT).
A. Greinacher +30 more
semanticscholar +1 more source